Urology Conference Coverage Archive

Genitourinary Cancers Symposium Urologic Cancer Surgery Readmission Rate Highest for RC

Urologic Cancer Surgery Readmission Rate Highest for RC

In a study, nearly 20% of radical cystectomy patients were readmitted for complications within 90 days compared with 1.9% and 5.9% for radical prostatectomy and radical nephrectomy, respectively.

Genitourinary Cancers Symposium Early Prostate Cancer Salvage ADT Therapy Better

Early Prostate Cancer Salvage ADT Therapy Better

Among men who had PSA failure following radiation therapy for localized PCa, those with a long PSA doubling time had an increased risk of PCa mortality if they started androgen-deprivation therapy later.

Genitourinary Cancers Symposium Prostate Cancer Pathologic Features Worse in Blacks

Prostate Cancer Pathologic Features Worse in Blacks

Black men undergoing radical prostatectomy for prostate cancer are more likely to have indications for adjuvant radiotherapy compared with white men.

Genitourinary Cancers Symposium Statin Use May Improve Survival in Advanced Prostate Cancer

Statin Use May Improve Survival in Advanced Prostate Cancer

Statin use is associated with greater overall survival among men with metastatic castration-resistant prostate cancer and improved survival among patients with high-risk prostate cancer.

Genitourinary Cancers Symposium Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign

Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign

In a study, a negative confirmatory prostate biopsy in prostate cancer patients on active surveillance predicts a lower risk of progressing to treatment.

Genitourinary Cancers Symposium Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk

Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk

In separate studies, apalutamide and enzalutamide prolonged metastasis-free survival in men with non-metastatic castration-resistant prostate cancer.

Genitourinary Cancers Symposium Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

In a study of hypogonadal men, those who received testosterone therapy had a lower incidence of prostate cancer than those who did not.

EAU Congress Predictors of Post-RARP Readmission Identified

Predictors of Post-RARP Readmission Identified

Patients with longer hospital stays and pre-discharge complications were at increased risk of readmission within 30 days of discharge.

EAU Congress Recurrence of Low-Risk RCC Uncommon After Surgery

Recurrence of Low-Risk RCC Uncommon After Surgery

In a study, the 5-year risk of recurrence was 4.8%, 18.1%, and 46.3% for patients with low-, intermediate-, and high-risk disease.

EAU Congress Prostate Cancer Active Surveillance Does Not Up Metastasis Risk

Prostate Cancer Active Surveillance Does Not Up Metastasis Risk

Study finds no difference in metastasis-free survival observed after 15 years compared with radiation therapy or radical prostatectomy.

Genitourinary Cancers Symposium Pre-Cystectomy Chemo Does Not Up Survival in 'Real World' Setting

Pre-Cystectomy Chemo Does Not Up Survival in 'Real World' Setting

Finding contrasts with results of randomized clinical trials.

Genitourinary Cancers Symposium Bladder Surgery Complications Predicted by New Model

Bladder Surgery Complications Predicted by New Model

Nomograms specific to radical cystectomy currently do not exist to aid stratification of a patient's risks for complications.

Genitourinary Cancers Symposium Biologics Combo Shows Promise As First-Line mRCC Therapy

Biologics Combo Shows Promise As First-Line mRCC Therapy

In a phase 2 trial, atezolizumab plus bevacizumab improved PFS versus sunitinib in patients with renal cell carcinoma expressing PD-L1.

Genitourinary Cancers Symposium Sunitinib Dose Escalation May Benefit mRCC Patients

Sunitinib Dose Escalation May Benefit mRCC Patients

Added progression-free survival and prolonged overall survival possible, according to investigators.

Genitourinary Cancers Symposium Kidney Cancer Brain Metastases Not On the Rise

Kidney Cancer Brain Metastases Not On the Rise

Researchers develop a model to predict which patients are more likely to harbor brain metastases at cancer diagnosis.

Genitourinary Cancers Symposium Single RCC Bone Metastasis Predicts Better Survival

Single RCC Bone Metastasis Predicts Better Survival

Bone surgery should be considered in patients with solitary bone metastasis and no concomitant visceral metastases, according to investigators.

Genitourinary Cancers Symposium PFS Longer With Abiraterone As Second-Line mCRPC Treatment

PFS Longer With Abiraterone As Second-Line mCRPC Treatment

Clinical or radiologic progression is less likely with abiraterone plus prednisone than cabazitaxel following first-line docetaxel, study finds.

Genitourinary Cancers Symposium PSA, PSAD Less Predictive of Aggressive PCa in Black Men

PSA, PSAD Less Predictive of Aggressive PCa in Black Men

Study finds that PSA and PSAD indicated prostate cancer above Gleason score 6 for white men only.

Genitourinary Cancers Symposium Adjuvant Radiation Therapy Common in MIBC

Adjuvant Radiation Therapy Common in MIBC

Survey finds that 46% of radiation oncologists have administered ART to patients with muscle-invasive bladder cancer on at least one occasion.

Genitourinary Cancers Symposium Post-Radical Cystectomy Survival Outcomes Predicted by Preop NLR

Post-Radical Cystectomy Survival Outcomes Predicted by Preop NLR

A neutrophil-to-lymphocyte ratio below 3.09 is associated with significantly longer overall and disease-specific survival.

Genitourinary Cancers Symposium Researchers Identify mCRPC Drug Sequence Offering the Best Survival

Researchers Identify mCRPC Drug Sequence Offering the Best Survival

In a retrospective study, patients lived the longest if they received docetaxel followed by cabazitaxel and then abiraterone or enzalutamide.

Genitourinary Cancers Symposium Urologists Support Targeted Biopsy

Urologists Support Targeted Biopsy

In a survey, 3 in 5 urologists in the United States indicated they perform MRI-US guided biopsy in current practice.

Genitourinary Cancers Symposium 5-Year PCa-Specific Mortality Declined With Increased PSA Testing

5-Year PCa-Specific Mortality Declined With Increased PSA Testing

From 1995 to 2011, prostate cancer deaths fell by 13.0% among Danish patients diagnosed with low-risk disease.

Genitourinary Cancers Symposium Prostate Cancer Treatment Prolongs Survival

Prostate Cancer Treatment Prolongs Survival

Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.

Genitourinary Cancers Symposium Higher BMI Lowers Death Risk in Men With Advanced Prostate Cancer

Higher BMI Lowers Death Risk in Men With Advanced Prostate Cancer

In a study, each 1-unit increment in body mass index was associated with a 16% lower mortality risk.

Genitourinary Cancers Symposium Black Patients May Be Adversely Affected by Less PSA Screening

Black Patients May Be Adversely Affected by Less PSA Screening

Black patients who met age criteria for PSA screening were 28% more likely to die of their prostate cancer than patients ineligible for screening.

Genitourinary Cancers Symposium Metastatic Prostate Cancer Death Rates Declining

Metastatic Prostate Cancer Death Rates Declining

Cancer-specific mortality rates dropped from 72.8% in 1995 to 55.8% in 2011, according to a Danish study.

Canadian Urological Association Smaller Renal Tumors Predict Longer Surgical Wait Times

Smaller Renal Tumors Predict Longer Surgical Wait Times

Patients whose surgical wait time was 3 months or more versus less than 3 months had 10-fold increased odds of having a smaller tumor.

Canadian Urological Association Deceased-Donor Age Affects Kidney Transplant Outcomes

Deceased-Donor Age Affects Kidney Transplant Outcomes

Recipients of kidneys from individuals who donated the organs after cardiac death are more likely to experience graft loss and delayed graft function.

Canadian Urological Association Metformin May Have a Protective Effect in Bladder Cancer Patients

Metformin May Have a Protective Effect in Bladder Cancer Patients

Diabetics taking the drug had a significant 68% decreased risk of grade progression compared with diabetics not on the drug.

Canadian Urological Association Hypercalciuria Linked to High Urinary Sodium

Hypercalciuria Linked to High Urinary Sodium

Decreasing salt intake could decrease the risk of recurrent kidney stones.

Canadian Urological Association New Study Supports Use of Trimodal Therapy for MIBC

New Study Supports Use of Trimodal Therapy for MIBC

Researchers find no difference in 5-year disease-specific survival between multi-disciplinary bladder-sparing approach and radical cystectomy.

Canadian Urological Association Smokers Face Delayed Continence Recovery After Prostate Surgery

Smokers Face Delayed Continence Recovery After Prostate Surgery

Large prostates and bladder neck sparing also predict longer time to return of continence.

Canadian Urological Association Testosterone Replacement Safe for Men With Prostate Cancer

Testosterone Replacement Safe for Men With Prostate Cancer

Findings emerge from a study of hypogonadal men who underwent radiation therapy, surgery, or active surveillance for prostate cancer.

Canadian Urological Association Visceral Fat Predicts Prostate Cancer Treatment Outcomes

Visceral Fat Predicts Prostate Cancer Treatment Outcomes

Greater visceral adipose tissue volume and density are associated with a lower the risk of biochemical recurrence.

Canadian Urological Association Cardiac Event Risk in PCa Patients Higher After Radiation Than Surgery

Cardiac Event Risk in PCa Patients Higher After Radiation Than Surgery

Radiation therapy also is associated with a greater likelihood of fractures.

Genitourinary Cancers Symposium NSAIDs May Raise Risk of Fatal Kidney Cancer

NSAIDs May Raise Risk of Fatal Kidney Cancer

Regular use of non-steroidal anti-inflammatory drugs for 10 years or more increased the risk of dying from renal cell carcinoma nearly 4-fold.

Genitourinary Cancers Symposium Metformin Lowers Death Risk in mRCC Patients on Sunitinib

Metformin Lowers Death Risk in mRCC Patients on Sunitinib

The protective effect was not observed with other anti-diabetic medications.

Genitourinary Cancers Symposium Nephrectomy as Initial mRCC Treatment Offers Survival Advantage

Nephrectomy as Initial mRCC Treatment Offers Survival Advantage

Patients who underwent upfront cytoreductive nephrectomy lived 6.4 months longer than those treated with upfront targeted therapy, a study found.

Genitourinary Cancers Symposium Healthy Lifestyle After PCa Diagnosis Beneficial

Healthy Lifestyle After PCa Diagnosis Beneficial

Through diet and exercise, prostate cancer patients can decrease their risk of dying from their illness.

Genitourinary Cancers Symposium Study: ADT, Radiotherapy Possibly Reduce Bladder Cancer Risk

Study: ADT, Radiotherapy Possibly Reduce Bladder Cancer Risk

The finding of lower bladder cancer incidence in patients receiving pelvic radiation contrasts with previous research.

Genitourinary Cancers Symposium Bladder Tumor Resection Key to Cystectomy Outcomes

Bladder Tumor Resection Key to Cystectomy Outcomes

Researchers estimate that 40% of pathologic response in MIBC patients receiving both neoadjuvant chemo and TURBT is due to TURBT.

Genitourinary Cancers Symposium Travel Distance to Provider Predicts Post-Cystectomy Readmission

Travel Distance to Provider Predicts Post-Cystectomy Readmission

A travel distance of more than 30 miles to the provider was associated with greater chances of readmission in one analysis.

Genitourinary Cancers Symposium Study: 5-ARIs Lower Prostate Cancer Progression Risk

Study: 5-ARIs Lower Prostate Cancer Progression Risk

Non-users of 5-alpha-reductase inhibitors had a nearly 2.6 times increased risk of pathologic progression than those who took the drugs.

Genitourinary Cancers Symposium CTC Heterogeneity Predicts Hormone Therapy Response in mCRPC

CTC Heterogeneity Predicts Hormone Therapy Response in mCRPC

Patients with higher heterogeneity score did not respond well to hormone therapy.

Genitourinary Cancers Symposium Radium-223 Repeat Treatment Safe, Effective

Radium-223 Repeat Treatment Safe, Effective

Second round of 6 injections was well tolerated and continued to control disease progression in bone.

Genitourinary Cancers Symposium Early PSA Response to Abiraterone Predicts Better Outcomes

Early PSA Response to Abiraterone Predicts Better Outcomes

A 50% or greater PSA decline at 15 days after start of treatment was associated with increased progression-free and overall survival.

Genitourinary Cancers Symposium Statins May Prolong Abiraterone Treatment Duration

Statins May Prolong Abiraterone Treatment Duration

Researchers observed a trend toward longer time on drug among men with castration-resistant prostate cancer.

Genitourinary Cancers Symposium Cabozantinib Improves PFS in Patients With Advanced RCC

Cabozantinib Improves PFS in Patients With Advanced RCC

The drug nearly doubled the delay in tumor growth compared with everolimus.

Genitourinary Cancers Symposium Aspirin May Reduce Risk of Lethal Prostate Cancer

Aspirin May Reduce Risk of Lethal Prostate Cancer

In large observational study, regular use—defined as 3 tablets per week—was associated with a 24% lower risk of dying from prostate cancer.

Genitourinary Cancers Symposium Bipolar Androgen Therapy Promising for Advanced Hormone-Sensitive PCa

Bipolar Androgen Therapy Promising for Advanced Hormone-Sensitive PCa

In a small study, high-dose testosterone given intermittently with androgen deprivation therapy lowered PSA levels without serious adverse effects.

Genitourinary Cancers Symposium Gene Signature May Predict PCa Hormone Treatment Failure

Gene Signature May Predict PCa Hormone Treatment Failure

A 12-gene androgen deprivation therapy resistance signature may help guide therapeutic decision making after radical prostatectomy.

Canadian Urological Association Obesity, Diabetes Hike Post-Cystectomy Surgical Site Infection Risk

Obesity, Diabetes Hike Post-Cystectomy Surgical Site Infection Risk

Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.

Canadian Urological Association No Worse Outcomes After Salvage Cystectomy for Bladder Cancer

No Worse Outcomes After Salvage Cystectomy for Bladder Cancer

Researchers found similar post-surgical outcomes between bladder cancer patients having primary and salvage radical cystectomy.

Canadian Urological Association Some Post-Cystectomy Risks Increase with Older Age, Comorbidities

Some Post-Cystectomy Risks Increase with Older Age, Comorbidities

A prolonged hospital stay and discharge to a nursing facility were among the risks.

Canadian Urological Association Laparoscopically Harvesting Right Kidneys from Living Donors Safe

Laparoscopically Harvesting Right Kidneys from Living Donors Safe

Donor and recipient outcomes are similar to those associated with laparoscopic removal of left donor kidneys.

Canadian Urological Association Local Tumor Ablation of Small Renal Masses Offers Survival Edge

Local Tumor Ablation of Small Renal Masses Offers Survival Edge

In a study, the treatment was associated with a 53% decreased risk of death from kidney cancer compared with expectant management.

Canadian Urological Association Reoperation Rate Low After HoLEP for Enlarged Prostate

Reoperation Rate Low After HoLEP for Enlarged Prostate

Ten years after the laser procedure, no reoperation was needed for 95% of patients treated for symptomatic benign prostatic hyperplasia.

Canadian Urological Association Prostatitis Found to Increase Prostate Cancer Risk

Prostatitis Found to Increase Prostate Cancer Risk

Researchers observe no association between prostate cancer and urethritis, orchitis, or epididymitis.

Canadian Urological Association Complications More Likely After Radiotherapy vs. Surgery for PCa

Complications More Likely After Radiotherapy vs. Surgery for PCa

Radiation treatment is associated with an increased risk of requiring minimally invasive urologic procedures.

Canadian Urological Association Enzalutamide Superior to Bicalutamide for mCRPC

Enzalutamide Superior to Bicalutamide for mCRPC

In a phase 2 trial, enzalutamide treatment was associated with significantly longer progression-free survival.

AUA 2015 Other Genitourinary Cancers Hematuria Evaluation in Primary Care Varies Widely

Hematuria Evaluation in Primary Care Varies Widely

Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.

AUA 2015 Other Genitourinary Cancers Urine Cytology Stain Detects Urothelial Carcinoma

Urine Cytology Stain Detects Urothelial Carcinoma

The test displayed an overall high sensitivity for detecting bladder tumors.

AUA 2015 Other Genitourinary Cancers Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

Men at high-risk of bladder cancer were the most likely to be referred to urologists.

AUA 2015 Prostate Cancer Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

Study reveals comparable rates of freedom from biochemical failure at 5 years.

AUA 2015 Other Genitourinary Cancers Early Tumor Shrinkage with TKIs Predicts mRCC Survival

Early Tumor Shrinkage with TKIs Predicts mRCC Survival

RCC tumor shrinkage significantly and independently predicted overall survival.

AUA 2015 Prostate Cancer Early ADT for Recurrent Prostate Cancer May Hike Death Risk

Early ADT for Recurrent Prostate Cancer May Hike Death Risk

This effect appears to occur mainly in men who experience recurrence when they are younger than 65 and in those with low-risk cancer.

AUA 2015 Other Genitourinary Cancers Neoadjuvant Sunitinib Linked to Improved Outcomes in RCC with Thrombus

Neoadjuvant Sunitinib Linked to Improved Outcomes in RCC with Thrombus

Neoadjuvant sunitinib was linked to primary tumor and thrombus shrinkage, reduced blood loss during surgery, as well as improved cancer-specific survival.

AUA 2015 Other Genitourinary Cancers Scrotal US for Pain Rarely Reveals Absolute Surgery Indications

Scrotal US for Pain Rarely Reveals Absolute Surgery Indications

Study shows that 81% of scrotal ultrasounds for pain demonstrate normal or benign findings.

AUA 2015 Other Genitourinary Cancers RCC Progression Rare After 10 Recurrence-Free Years Post-Nephrectomy

RCC Progression Rare After 10 Recurrence-Free Years Post-Nephrectomy

Pathological stage was the only independent factor linked to kidney cancer progression.

AUA 2015 Other Genitourinary Cancers 'Real-World' Patient Compliance with Bladder CA Therapy Poor

'Real-World' Patient Compliance with Bladder CA Therapy Poor

Researchers find rates lower than those observed in most clinical trials.

AUA 2015 Other Genitourinary Cancers Intensive Local Therapy to RCC Bone Metastases May Increase Survival

Intensive Local Therapy to RCC Bone Metastases May Increase Survival

The approach was defined as surgical resection with a wide margin or radiotherapy with a biologically effective dose of 140 Gy or greater.

AUA 2015 General News Delayed Stone Treatment Increases Morbidity

Delayed Stone Treatment Increases Morbidity

Unplanned clinical visits 15 times more likely among patients treated more than 45 days after diagnosis.

AUA 2015 Other Genitourinary Cancers Metastasectomy May Up Survival in Metastatic RCC Patients

Metastasectomy May Up Survival in Metastatic RCC Patients

In a study, patients who had the procedure had a better 5-year overall survival rate than those who did not (68% vs. 27%).

AUA 2015 Other Genitourinary Cancers Larger RCC Tumors Predict High-Grade Pathology

Larger RCC Tumors Predict High-Grade Pathology

New finding may inform treatment decisions.

AUA 2015 General News Larger Stones Hike Re-treatment Risk After Shock Wave Lithotripsy

Larger Stones Hike Re-treatment Risk After Shock Wave Lithotripsy

Patients with kidney or ureteral stones larger than 20 mm are 85% more likely be re-treated those those with stones smaller than 10 mm.

AUA 2015 Men's Health Testosterone Therapy Safe in Hypogonadal Elderly Men

Testosterone Therapy Safe in Hypogonadal Elderly Men

In a study of hypogonadal men older than 65, the treatment did not increase the prevalence of thrombotic events.

AUA 2015 Prostate Cancer DRE Has Limited Value for Prostate Cancer Screening

DRE Has Limited Value for Prostate Cancer Screening

Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.

AUA 2015 General News Flexible Ureteroscopy May Beat ESWL for Pediatric Stone Patients

Flexible Ureteroscopy May Beat ESWL for Pediatric Stone Patients

Flexible ureteroscopy achieved a stone-free rate nearly twice as high as that achieved with extracorporeal shock wave lithotripsy.

AUA 2015 Prostate Cancer Post-RP Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

Post-RP Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

Gleason 9-10 tumors are associated with a greater risk of biochemical and clinical recurrence, but not overall survival.

AUA 2015 Prostate Cancer Radical Prostatectomy Offers Excellent Long-Term Outcomes

Radical Prostatectomy Offers Excellent Long-Term Outcomes

Researchers report on a study in which survivors were followed up for a median of 14 years.

AUA 2015 Men's Health Testosterone Therapy May Benefit Hypogonadal CP/CPSS Sufferers

Testosterone Therapy May Benefit Hypogonadal CP/CPSS Sufferers

Patients experienced significant improvements in symptoms and quality of life parameters.

AUA 2015 Prostate Cancer Surgical Margin Status Has No Effect on PCa Patient Survival

Surgical Margin Status Has No Effect on PCa Patient Survival

Researchers concluded that margin status is a surrogate for established risk criteria.

AUA 2015 General News OAB Drugs Prescribed Less Frequently to Men

OAB Drugs Prescribed Less Frequently to Men

A study found that 33.8% of women received anticholinergics compared with 19.4% of men.

AUA 2015 Men's Health Poor Sexual Health Knowledge Common in Young Minority Men

Poor Sexual Health Knowledge Common in Young Minority Men

Survey of minority men aged 18-25 showed that 57.2% indicated that they or their partner did not use birth control at their last sexual encounter.

AUA 2015 Prostate Cancer Elevated NLR Linked to Worse Post-RP Outcomes

Elevated NLR Linked to Worse Post-RP Outcomes

Neutrophil-lymphocyte ratio could have a prognostic role in localized prostate cancer.

AUA 2015 General News Overactive Bladder Increases Falling Risk in the Elderly

Overactive Bladder Increases Falling Risk in the Elderly

OAB treatment is associated with a decreased risk of falls, study finds.

AUA 2015 Other Genitourinary Cancers UTI Linked to Worse Bladder Cancer Outcomes

UTI Linked to Worse Bladder Cancer Outcomes

Greater effects were seen in women with UTI, according to researchers.

AUA 2015 Other Genitourinary Cancers Blood-Based Biomarkers May Predict Bladder Cancer Outcomes

Blood-Based Biomarkers May Predict Bladder Cancer Outcomes

Levels of CEA and CA 19-9 were significantly higher in patients with tumor recurrence and/or progression.

AUA 2015 Other Genitourinary Cancers Pts at High Risk of Bladder CA More Likely to Die of Other Causes

Pts at High Risk of Bladder CA More Likely to Die of Other Causes

Screened patients were more likely to die from other smoking-related malignancies.

AUA 2015 General News SICU Readmission More Likely Among Urologic Surgery Patients

SICU Readmission More Likely Among Urologic Surgery Patients

The most common cause is respiratory compromise.

AUA 2015 Prostate Cancer RALP Offers Favorable Long-Term Prostate Cancer Control

RALP Offers Favorable Long-Term Prostate Cancer Control

The 10-year rates of biochemical and clinical recurrence are comparable to those of open surgery.

AUA 2015 Other Genitourinary Cancers Socioeconomic Predictors of Metastatic Clear-Cell RCC Identified

Socioeconomic Predictors of Metastatic Clear-Cell RCC Identified

It is important to assess factors that may put patients at higher risk of metastatic disease, according to researchers.

AUA 2015 Other Genitourinary Cancers Neutrophil to Lymphocyte Ratio May Predict NMIBC Recurrence

Neutrophil to Lymphocyte Ratio May Predict NMIBC Recurrence

Patients who experienced recurrence had a higher ratio than those who did not.

AUA 2015 Other Genitourinary Cancers ACE Inhibitors, ARBs May Improve NMIBC Outcomes

ACE Inhibitors, ARBs May Improve NMIBC Outcomes

Use of the medications was associated with a significant 39% decreased risk of tumor recurrence after surgery.

AUA 2015 Prostate Cancer PCa Metastasis Predictors in Active Surveillance Patients ID'd

PCa Metastasis Predictors in Active Surveillance Patients ID'd

A PSA doubling time of less than 3 years and a Gleason score of 8-10 were associated with an increased risk of metastasis.

AUA 2015 Men's Health Testosterone Replacement Use Low Among Hypogonadal Men

Testosterone Replacement Use Low Among Hypogonadal Men

Hypogonadism was present in 42.8% of subjects, yet TRT was used by only 3.9%.

AUA 2015 Men's Health Penile Prosthesis Use Declining in U.S.

Penile Prosthesis Use Declining in U.S.

Insertion of these devices decreased from 4.6% of erectile dysfunction cases in 2002 to 2.3% in 2010.

AUA 2015 General News Non-Whites Less Likely to Receive Narcotics for Stone Pain

Non-Whites Less Likely to Receive Narcotics for Stone Pain

Study shows no racial disparity in the use of non-steroidal anti-inflammatory drugs.

Sign Up for Free e-newsletters